US pharmaceutical trials of the French abortion pill RU-486 are expected to begin this fall, with 2000 women to be enrolled at 12 clinical sites. J Am Osteopath Assoc 1994;94(6):468B. doi: 10.7556/jaoa.19188.8.131.528B.
Download citation file:
This PDF is available to Subscribers Only
View Article Abstract & Purchase Options